2019 Cannabis Business Award's
Publication of the Year |
NEXT ZOOM MEETING WILL BE ON WEDNESDAY, JULY 12, 2023 AT 6:30PM THE "FLORIDA MEDICAL CANNABIS PHYSICIAN GROUP" (FMCPG)
FOR ALL "MEDICAL MARIJUANA DOCTORS" AND "MMTC DIRECTORS ONLY " TOPICS TO BE DISCUSSED WHAT YOU NEED TO KNOW ABOUT THE NEW TELEHEALTH BILL FOR CANNABIS PATIENTS JUST SIGNED BY THE GOVERNOR UPDATE FROM TALLAHASSEE ON THE HEMP BILL PROTECTING YOUR MEDICAL CANNABIS PRACTICE QUESTIONS FROM PHYSICIANS HOW TO BEST ANSWER YOUR PATIENT QUESTIONS |
DESANTIS SIGNS BILL PROHIBITING MEDICAL MARIJUANA AT FLORIDA RECOVERY RESIDENCES EVEN IF RECOMMENDED BY DOCTOR
Florida Gov. Ron DeSantis (R), a 2024 Republican presidential candidate, has signed a bill that expressly prohibits sober living facilities from allowing residents to possess or use medical marijuana, even if the patient is certified by a doctor to legally use cannabis therapeutically in accordance with state law. All other doctor-prescribed pharmaceutical medications may be permitted, however.
The governor signed the legislation, SB 210, on Tuesday—and he separately gave final approval to a hemp regulations measure that bans the sale of legal smokeless hemp products to people under 21.
Under the newly enacted SB 210, applicants who are seeking licensing to operate recovery residences under the state Department of Children and Families will need to affirm that they do not permit the use of cannabis, which “includes marijuana that has been certified by a qualified physician for medical use.”
But residents may continue to use other pharmaceutical drugs prescribed by doctors, so the law explicitly singles out medical marijuana.
READ MORE |
NEWS FROM THE PAST WEEK
RELATING TO THE BUSINESS OF CANNABIS IN FLORIDA Click on Company Logo to be Transferred to Web Site |
TRULIEVE ANNOUNCES OPENING OF MEDICAL CANNABIS DISPENSARY IN NEWNAN, GA
New dispensary expands patient access to medical cannabis in the state
TALLAHASSEE, Fla., June 28, 2023 — Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company in the United States, today announced the grand opening of Trulieve’s third medical cannabis dispensary in the state.
Momenta™ THC tinctures, empower your wellness journey, active lifestyle, and could help support a good night’s sleep! Tinctures are one of the best methods of consumption for precise and/or micro-dosing. Ingested either in its liquid form or can be mixed in food or beverages. These cannabis tinctures work quickly, with prolonged effects. Available in CBD, THC, and ratio options and a variety of flavors.
“We are proud to continue expanding access to the growing number of registered medical patients in Georgia,” said Kim Rivers, CEO of Trulieve. “Our new dispensary in Newnan will bring our exceptional customer experience and top-quality products to a new community we can’t wait to serve.”
READ MORE |
TRULIEVE SPARKS MARYLAND RECREATIONAL SALES ON JULY 1
Customer specials with local flair, swag, demonstrations, and clone sales planned in Rockville, Halethorpe and Lutherville
June 29, 2023 — Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company in the United States, today announced customer specials planned in Halethorpe, Lutherville and Rockville, MD with the company’s signature quality cannabis clones available for limited sale at each location.
“We are proud to be part of history as the state expands to include adult use,” said Kim Rivers, CEO of Trulieve. “We look forward to commemorating the occasion on Saturday alongside the many Marylanders who voted for the freedom to use cannabis for personal consumption.”
READ MORE
|
CRESCO LABS AND COLUMBIA CARE PROVIDE UPDATE ON TRANSACTION
CHICAGO — Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or “the Company), and Columbia Care (NEO:CCHW) (CSE:CCHW) (OTCQX:CCHWF) (“Columbia Care”), today announced that they will not be able to complete the divestitures necessary to secure all necessary regulatory approvals to close the pending transaction by the outside date of June 30, 2023 that is specified in the arrangement agreement dated March 23, 2022 and amended on February 27, 2023. At this stage, Cresco and Columbia Care are working amicably with respect to the next steps in relation to the transaction and will provide further updates in the near future.
READ MORE |
COLUMBIA CARE TO BEGIN ADULT USE SALES IN THREE MARYLAND RETAIL LOCATIONS ON JULY 1
Columbia Care Chevy Chase, gLeaf Rockville, gLeaf Frederick, and the Company’s Cultivation and Production are Prepared for Adult Use
June 30, 2023– Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”), one of the largest and most experienced cultivators, manufacturers and retailers of cannabis products in the U.S., today announced it is set to begin adult use sales in its three Maryland retail locations, Columbia Care Chevy Chase, gLeaf Rockville and gLeaf Frederick, on Saturday, July 1.
“The start of adult use sales in Maryland is a truly momentous occasion for our customers and for the industry as a whole. We continue to see some states taking immediate action on ballot initiatives across the country and working diligently to put a framework together to build a broader, safer and more inclusive cannabis marketplace with the introduction of adult use sales. This swift action, and inclusion of existing operators who understand the landscape, shows a commitment from state leaders to help connect the power of the cannabis plant to those who need and want it,” said Jesse Channon, Chief Growth Officer, Columbia Care. “We are proud to be a part of the initial adult use framework and look forward to continuing to serve the medical community as we have for years.”
READ MORE |
NEW NAME HOUSE OF PLATINUM CANNABIS |
CRESCO LABS ADDS TWO DISPENSARIES IN WASHINGTON AND SOMERSET TO PENNSYLVANIA FOOTPRINT
CHICAGO – JUNE 29, 2023 – Cresco Labs (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or “the Company”), a vertically integrated, multi-state operator and the cannabis industry’s No. 1 producer of branded products, today announced the opening of Sunnyside Washington and Sunnyside Somerset in the Commonwealth of Pennsylvania.
“We’re excited to open the first dispensary in Somerset, as well as expand access to medical marijuana products through a location that’s easily accessible to patients and caregivers in Washington,” said Charlie Bachtell, CEO and Co-founder of Cresco Labs. “Pennsylvania is a core market where we continue to make strategic investments like improving our productivity, opening more dispensaries and broadening access to our bestselling branded portfolio of flower, vapes and concentrates to maintain our number one share.”
READ MORE |
CRESCO LABS ANNOUNCES VOTING RESULTS OF ITS ANNUAL MEETING OF SHAREHOLDERS
July 3, 2023 - Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco Labs” or “the Company”), a vertically integrated, multi-state operator and the cannabis industry’s No. 1 producer of branded products, conducted its annual meeting of shareholders (the “Meeting”) on June 30, 2023 at 11 a.m. (Eastern Time).
At the Meeting, the number of directors on the board of directors of the Company for the ensuing year was fixed at ten (10) by the shareholders and the following nominees for election as directors of the Company were elected by a majority of votes cast by the shareholders virtually present or represented by proxy at the Meeting:
Charles Bachtell
Robert M. Sampson
John R. Walter
Gerald F. Corcoran
Thomas J. Manning
Randy D. Podolsky
Marc Lustig
Michele Roberts
Carol Vallone
Tarik Brooks
Further, Marcum LLP was reappointed as the Company’s auditor for the ensuing year.
READ MORE |
SURTERRA WELLNESS AND WANA BRANDS ANNOUNCE LAUNCH OF WANA PREMIUM CANNABIS-INFUSED GUMMIES ACROSS ALL SURTERRA DISPENSARIES IN FLORIDA
June 29, 2023 – Surterra Wellness (Surterra), the retail brand of vertically integrated multi-state cannabis company Parallel, and Wana Brands, North America’s leading cannabis edibles producer, today announced Wana’s cannabis-infused gummies will now be available to Floridians in all Surterra dispensaries as of June 29, 2023.
“We are thrilled to partner with Wana Brands – a grassroots, women-owned, innovation-focused company – to bring their premium products to medical marijuana patients across the state of Florida,” said Lynnette French, Chief Operating Officer of Parallel. “Surterra is proud to expand our offerings of world-class products, such as Wana, and continue delivering the high-quality services Surterra is known for.”
“For more than a decade, Wana has been focused on formulating products for patients who want to access the healthful compounds of the cannabis plant,” said Nancy Whiteman, Co-Founder & CEO, Wana Brands. “Parallel’s outstanding network of Surterra dispensaries throughout Florida provides patients with Wana’s proven products in refreshing flavors–such as Watermelon and Yuzu–for a range of needs from sleep to stress.”
READ MORE |
VERANO CONTINUES FLORIDA RETAIL EXPANSION WITH OPENING OF MÜV VENICE, THE COMPANY’S 69TH FLORIDA LOCATION AND 130TH RETAIL LOCATION IN THE NATION
MÜV Venice is located at 4369 South Tamiami Trail, a busy thoroughfare with an average daily traffic count of 30,500 vehicles1
The dispensary is located in Sarasota County, a growing region with a population of over 462,0002
Verano’s active operations span 13 states, comprised of 130 dispensaries and 14 cultivation and processing facilities with more than 1 million square feet of cultivation capacity
CHICAGO, June 29, 2023 — Verano Holdings Corp. (CSE: VRNO) (OTCQX: VRNOF) (“Verano” or the “Company”), a leading multi-state cannabis company, today announced the opening of MÜV Venice on Friday, June 30, the Company’s 69th Florida dispensary and 130th retail outlet nationwide. MÜV Venice is located at 4369 South Tamiami Trail, and will be open Monday through Saturday from 9 a.m. to 7 p.m. and Sunday from 11 a.m. to 5 p.m., local time.
According to Florida’s Office of Medical Marijuana Use, there are currently over 828,000 qualified medical cannabis patients in the state. Florida medical cannabis sales are projected to potentially reach $2.6 billion by 2027, as reported by MJBiz Factbook 2023.
“MÜV Venice marks our fourth dispensary in Sarasota County, providing another convenient location for Florida’s medical cannabis patients to access our wide variety of high quality products,” said John Tipton, President of the Southern Region. “We look forward to introducing our signature, elevated retail experience to the Venice community, and continuing to deliver on our promise to provide the best cannabis products and patient-centric hospitality to Florida’s medical marijuana community.”
READ MORE |
VERANO TO WELCOME CANNABIS CUSTOMERS AT ZEN LEAF RETAIL LOCATIONS ON JULY 1 TO COMMEMORATE HISTORIC LAUNCH OF ADULT USE SALES IN MARYLAND
June 30, 2023 — Verano Holdings Corp. (CSE: VRNO) (OTCQX: VRNOF) (“Verano” or the “Company”), a leading multi-state cannabis company, today announced that on Saturday, July 1, the Company will commence adult use cannabis sales in Maryland at its four Zen Leaf retail locations across the state beginning at 9 a.m. ET local time. Verano will welcome state and local leaders at its Zen Leaf Elkridge location, and participation from local Chambers of Commerce across all locations, for ceremonial ribbon cuttings prior to welcoming the state’s first adult use customers and commemorating the end of cannabis prohibition in Maryland.
Established in 2017, Verano’s Maryland operations include a state-of-the-art 38,000 square foot cultivation and processing facility in Jessup, and the Company’s four Zen Leaf retail locations in Elkridge, Germantown, Pasadena and Towson. Nationally, Verano’s active operations span 13 states, comprised of 130 dispensaries and 14 cultivation and processing facilities with more than 1 million square feet of cultivation capacity.
READ MORE |
PLANET 13 ANNOUNCES THE RETURN OF CANNABITION, AN IMMERSIVE CANNABIS EXPERIENCE DESIGNED BY RENOWNED BROADWAY CREATIVE DIRECTOR DAVID KORINS, COMING SOON TO THE LAS VEGAS SUPERSTORE
June 29, 2023 – Planet 13 Holdings Inc. (CSE:PLTH)(OTCQX:PLNHF) (“Planet 13” or the “Company”), a leading vertically-integrated multi-state cannabis company, today announced the return of Cannabition (headed by Keneh Ventures), a brand-new 12,000 square foot whimsical and visually breathtaking environment, tailor-made for cannabis enthusiasts seeking an awe-inspiring and “Instagrammable” experience.
Leading the charge as Creative Director is David Korins, the visionary genius behind the dazzling sets of Broadway’s most iconic recent blockbusters, including Hamilton, Dear Evan Hansen, Beetlejuice, and many more. Recently recognized as one of AdWeek’s ‘Creative 100,’ Korins brings his unparalleled creativity and expertise to spearhead the mesmerizing design of Cannabition’s 12,000 square foot presence.
READ MORE |
NATIONAL AND INTERNATIONAL NEWS |
JUSHI HOLDINGS INC. COMPLETES PREVIOUSLY DISCLOSED AMENDMENTS TO 12% SECOND LIEN NOTES AND WARRANTS
BOCA RATON, Fla., June 30, 2023 — Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH) (OTCQX: JUSHF), a vertically integrated, multi-state cannabis operator, announced today that it has completed the amendments (the “Amendments”) to the Company’s 12% Second Lien Notes (the “Notes”) and detached warrants expiring December 7, 2026 (the “Warrants”) previously disclosed in the Company’s press release dated June 6, 2023. The Company entered into definitive documentation evidencing the Amendments with the trustee to amend the trust indenture (with respect to the Notes) and with the collateral agent to amend the warrants (with respect to the Warrants).
The Amendments include the removal of a covenant in the trust indenture giving the right to holders of Notes to require the Company to repurchase the Notes for 105% of outstanding principal and accrued and unpaid interest upon a change of control, and a reduction of the exercise price of the Warrants for each subordinate voting share from US$2.086 to US$1.00.
READ MORE
|
DELTA 9 CANNABIS INC. ANNOUNCES VOTING RESULTS FOR ITS 2023 ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDERS
WINNIPEG, Manitoba, June 30, 2023 — DELTA 9 CANNABIS INC. (TSX: DN) (OTCQX: DLTNF) (“Delta 9” or the “Company”), announced today the voting results on the election of directors from its 2023 annual general and special meeting of shareholders of the Company (the “Meeting”).
A total of 40,205,444 common shares of the Company (“Shares”) representing 24.86% of the 161,737,167 issued and outstanding Shares were voted in connection with the Meeting. Shareholders approved all items of business before the Meeting, including the election of directors as follows:
John William Arbuthnot III
John William Arbuthnot IV
Nitin Kaushal
Stuart Starkey
Hugh Aird
READ MORE
|
PERVASIP ANNOUNCES EXPANSION INTO CALIFORNIA MARKET
SEATTLE, June 29, 2023 — Pervasip Corp. (OTCPK: PVSP) (“Pervasip” or the “Company”), a developer of companies and technologies in high value emerging markets, such as Artizen Corporation, a wholly owned subsidiary, today announced that it is setting up Artizen Nano in Los Angeles, CA for expansion into the California cannabis market and to that extent has signed a Letter of Intent with MTN Group to enter into Definitive Agreements by end of July 2023.
Continuing its previously announced targeted expansion plans, Artizen Nano will manufacture and distribute its Slurped nano beverages in the Los Angeles market as the second step of Artizen’s Westcoast expansion. This is done in partnership with MTN Group, with whom the Company has also signed a Letter of Intent to distribute the Slurped product line to its network of retailers. The Slurped brand is developing various additional collaborations with other brands.
READ MORE |
ATLAS GLOBAL PROVIDES UPDATE ON LIQUIDATION OF SUBSIDIARIES PURSUANT TO ORGANIZATIONAL RESTRUCTURE TO ACCELERATE GROWTH
CHATHAM, ONTARIO and TEL-AVIV, ISRAEL, June 27, 2023 — Atlas Global Brands Inc. (“Atlas Global”, or the “Company”) (CSE: ATL) announced today that further to the Company’s news release dated June 2, 2023, Ernst & Young Inc. has been appointed as receiver and manager (the “Receiver”) over certain current and future assets of Atlas Biotechnologies Inc. (“ABL”), a direct wholly-owned subsidiary of the Company, and Atlas Growers Ltd. (together with Atlas Biotechnologies, the “Atlas Subsidiaries”), an indirect wholly-owned subsidiary of the Company, under the Bankruptcy and Insolvency Act (Canada) and the Personal Property Security Act (Alberta).
The Atlas Subsidiaries’ senior lender, the Agriculture Financial Services Corporation (the “AFSC”), obtained the receivership order from the Court of King’s Bench of Alberta (the “Court”) with the consent of the Atlas Subsidiaries. The order follows on the Company’s decision to cease operations at its facility in Gunn, Alberta and liquidate the assets of the Atlas Subsidiaries in an orderly manner as it focuses on cost reductions, savings and production efficiencies across its operations and the cannabis value chain. A copy of the order is or soon will be available on the Receiver’s website which can be accessed at https://documentcentre.ey.com/.
READ MORE |
BELOW ARE THE LINKS TO THE DIRECTORY OF FLORIDA CANNABIS DOCTORS AND
DISPENSARIES IN THE STATE OF FLORIDA |
QUALIFIED PATIENTS OVER 830,000 AND 579 DISPENSING LOCATIONS
|
LATEST OMMU REPORTS FROM OFFICE OF MEDICAL MARIJUANA USE IN THE STATE OF FLORIDA Highlights from
JUNE 30, 2023 Report
BY THE NUMBERS Qualified Patients: (Active ID Card):
JUN 30 2023- 830,191 JUN 23 2023- 828,560 JUN 16 2023- 827,090
JUN 09 2023- 825,109 JUN 02 2023- 822,818 Patients Last Week: 1,631
Qualified Ordering Physicians: 2,545
New Doctors Last Week: 18 Reporting Period: JUNE 23 TO JUNE 29 2023 Amount of Medical Marijuana Dispensed - (mgs THC) 321,316,055
Amount of Low-THC Cannabis Dispensed - (mgs CBD) 3,500,670
Amount of Marijuana in a From for Smoking (oz) 110,771.191 Approved Dispensing Locations: 579 ADD LAST WEEK +1 MUV - FORT PIERCE |
UPCOMING MEETING AND CONFERENCES |
ADVERTISEMENT OPPORTUNITIES
If your goal is to get your business in front of the right people in the cannabis industry or you want to be an integral part of this new and exciting business opportunity, then you need to join with Cannabis News Florida as we help to establish cannabis as a major part of the economy in Florida. Cannabis News Florida is an online publication focusing on both local and national news from leading authorities about the medical and business developments in the medical cannabis industry covering the entire state of Florida.
Join the Cannabis News Florida force online and in print. We offer several marketing options to fit all budgets:
· MMTC PROMOS LISTED IN EACH E-NEWSLETTER
• Directory Listing
• Banner Ads
• Ad Space in the Newspaper
• Feature Articles
• Weekly Newsletters
For further information or to make your ad reservation, please call:561-368-6950 / 954-605-4785 cell charles@cannabisnewsflorida.com
|
|
|